ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 106 filers reported holding ATHIRA PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,370,690 | -31.5% | 3,153,807 | 0.0% | 0.04% | -31.5% |
Q2 2023 | $9,303,731 | +58.3% | 3,153,807 | +34.2% | 0.05% | +68.8% |
Q1 2023 | $5,875,888 | -1.4% | 2,350,355 | +25.0% | 0.03% | -11.1% |
Q4 2022 | $5,959,080 | +92.8% | 1,879,836 | +80.6% | 0.04% | +80.0% |
Q3 2022 | $3,091,000 | -2.6% | 1,040,834 | 0.0% | 0.02% | +11.1% |
Q2 2022 | $3,175,000 | -70.8% | 1,040,834 | +29.1% | 0.02% | -71.4% |
Q1 2022 | $10,886,000 | +3.6% | 806,367 | 0.0% | 0.06% | +23.5% |
Q4 2021 | $10,507,000 | +38.9% | 806,367 | 0.0% | 0.05% | +54.5% |
Q3 2021 | $7,564,000 | -8.4% | 806,367 | 0.0% | 0.03% | -8.3% |
Q2 2021 | $8,257,000 | -44.3% | 806,367 | 0.0% | 0.04% | -43.8% |
Q1 2021 | $14,837,000 | -46.3% | 806,367 | 0.0% | 0.06% | -38.5% |
Q4 2020 | $27,618,000 | +69.6% | 806,367 | -8.6% | 0.10% | +60.0% |
Q3 2020 | $16,288,000 | – | 882,352 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VR Adviser, LLC | 1,691,623 | $57,938,000 | 8.52% |
ACUTA CAPITAL PARTNERS, LLC | 393,000 | $13,460,000 | 3.66% |
Logos Global Management LP | 947,873 | $32,465,000 | 2.78% |
RTW INVESTMENTS, LP | 2,685,779 | $88,899,000 | 1.49% |
Avidity Partners Management LP | 1,043,873 | $35,753,000 | 1.16% |
Perceptive Advisors | 3,114,805 | $106,682,000 | 1.14% |
Sofinnova Investments, Inc. | 509,168 | $17,439,000 | 1.04% |
HighVista Strategies LLC | 32,062 | $1,098,000 | 0.70% |
Rock Springs Capital Management LP | 860,902 | $29,486,000 | 0.62% |
PFM Health Sciences, LP | 470,227 | $16,105,000 | 0.57% |